A single-injection vaccine for the polio virus
22 May 2018 | By European Pharmaceutical Review
Nanoparticles could offer a new way to help eradicate the disease worldwide...
List view / Grid view
Vaccine Technology
Cancer vaccine strategy blocks death of tumour-specific cytotoxic T cells
2 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
New research could serve as the stepping-stone in constructing vaccines with a greater likelihood of finding and attacking...
Vaccine suppresses peanut allergies in mice
13 April 2018 | By European Pharmaceutical Review
Researchers aim to develop a new immunotherapy that could alter the immune reactions to food. The result: Extended relief from peanut allergies...
Injectable sensor could provide unobtrusive, long-term alcohol monitoring
12 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Engineers have developed a miniature, ultra-low power injectable biosensor that could be used for continuous, long-term alcohol monitoring...
Researchers develop injectable bandage to promote haemostasis
4 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers have used kappa-carrageenan and nanosilicates to form injectable hydrogels to promote haemostasis and facilitate wound healing...
NIH scientists say advanced vaccines could limit future outbreaks
27 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Novel vaccine technologies are critical to improving the public health response to infectious disease threats that continually emerge and re-emerge, according to scientists at the NIAID...
Antigen study provides a new approach to vaccine development for RSV
13 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Medical researchers point to a promising route for designing an effective vaccine for the respiratory syncytial virus...
Strategic plan for developing a universal influenza vaccine unveiled
1 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
NIAID officials detail the Institute’s new strategic plan for addressing the research areas essential to creating a safe and effective universal influenza vaccine...
TB vaccine trial results offer potential for BCG revaccination
19 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Study is the first 'prevention of infection' trial conducted for tuberculosis, the world's leading infectious disease killer...
Injectable self-assembled nanomaterials developed for sustained drug delivery
13 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
New injectable delivery system can slowly release drug carriers for months...
Robotic method isolates high-producing cell lines for HIV vaccine production
6 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Technical advances in vaccine production should shorten the time to clinical trials, breaking the logjam of promising new candidate vaccines waiting to be tested...
Gene-based Zika vaccine is safe and immunogenic in healthy adults
7 December 2017 | By European Pharmaceutical Review
Results from two Phase 1 clinical trials show an experimental Zika vaccine is safe and induces an immune response in healthy adults.
Virus-like particle vaccine protects against RSV vaccine-enhanced respiratory disease
24 November 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers have discovered that a virus-like particle vaccine can prime the body's immune response and prevent the severe respiratory diseases...
Maternal immunisation
3 March 2016 | By Emmanuel Hanon, Senior Vice President, Head of Vaccines Research & Development, GSK
Here, GSK's Emmanuel Hanon discusses maternal vaccination and how it has emerged as a promising public health strategy...
GSK’s candidate shingles vaccine demonstrates 90% efficacy against shingles
28 October 2015 | By Kate Douetil
GSK’s candidate shingles vaccine is a non-live vaccine and combines gE, a protein found on the virus that causes shingles with an adjuvant system, AS01B, which enhances the immunological response to gE...
Follow: